Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 239-491-3 | CAS number: 15471-17-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2001-09-07 - 2001-10-12
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP-guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- No new study has been conducted; data from a existing GLP-guideline study (2001) has been used as this study is totally sufficient to cover this endpoint.
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: David Hall Limited, Burton-on-Trent, Staffordshire, UK
- Age at study initiation: approximately eight to twelve weeks
- Weight at study initiation: 300 to 450g,
- Housing: housed singly or in pairs in solid-floor polypropylene cages furnished with woodflakes
- Diet (e.g. ad libitum): Free access to and food (Certified Guinea Pig Diet (Code 5026) supplied by PMI Nutrition International, Nottingham, UK) was allowed throughout the study. The diet was routinely analysed and was considered not to contain any contaminant that could reasonably be expected to affect the purpose or integrity of the study
- Water (e.g. ad libitum): Free access to mains tap water was allowed throughout the study. The drinking water was routinely analysed and was considered not to contain any contaminant that could reasonably be expected to affect the purpose or integrity of the study
- Acclimation period: at least five days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17 to 23°C
- Humidity (%): 30 to 70%
- Air changes (per hr): at least fifteen changes per hour
- Photoperiod (hrs dark / hrs light): twelve hours continuous light (06:00 to 18:00) and twelve hours darkness
OTHER:
- each animal was selected at random and given a number unique within the study which was written on a small area of clipped rump using a black indelible marker-pen
- the animals were provided with environmental enrichment items which were considered not to contain any contaminant of a level that might have affected the purpose or integrity of the study - Route:
- intradermal
- Vehicle:
- other: distilled water
- Concentration / amount:
- Based on the results of sighting tests, the concentrations of test material for the induction and challenge phases were selected as:
Intradermal Induction: 5% w/w in distilled water
Topical Induction: 75% w/w in distilled water
Topical Challenge: 75% and 50% w/w in distilled water - Route:
- epicutaneous, occlusive
- Vehicle:
- other: distilled water
- Concentration / amount:
- Based on the results of sighting tests, the concentrations of test material for the induction and challenge phases were selected as:
Intradermal Induction: 5% w/w in distilled water
Topical Induction: 75% w/w in distilled water
Topical Challenge: 75% and 50% w/w in distilled water - No. of animals per dose:
- Ten test and five control animals
- Details on study design:
- RANGE FINDING TESTS:
Selection of Concentrations for Main Study (Sighting Tests)
The concentrations of test material to be used at each stage of the main study were determined by 'sighting tests' in which groups of guinea pigs were treated with various concentrations of test material. The procedures were as follows:
Selection of Concentration for Intradermal Induction: Intradermal injections (0.1 mL/injection site) were made on the clipped shoulder of two guinea pigs, using concentrations of 1% and 5% w/w in distilled water. The degree of erythema at the injection sites was assessed approximately 24, 48, 72 hours and 7 days after injection. The degree of oedema was not evaluated. Any evidence of systemic toxicity was also recorded. The highest concentration that caused only mild to moderate skin irritation, and which was well tolerated systemically, was selected for the intradermal induction stage of the main study.
Selection of Concentration for Topical Induction: Two guinea pigs (intradermally injected with Freund's Complete Adjuvant eight days earlier) were treated with four preparations of the test material (75%, 50%, 25% and 10% w/w in distilled water). Applications were made to the clipped flanks under occlusive dressings for an exposure period of 48 hours. The degree of erythema and oedema was evaluated approximately 1, 24 and 48 hours after dressing removal. The highest concentration producing only mild to moderate dermal irritation was selected for the topical induction stage of the main study.
Selection of Concentration for Topical Challenge: Four preparations of the test material (75%, 50%, 25% and 10% w/w in distilled water) were applied to the clipped flanks of two guinea pigs under occlusive dressings for an exposure period of 24 hours. These guinea pigs did not form part of the main study but had been treated identically to the control animals of the main study, up to Day 14. The degree of erythema and oedema was evaluated approximately 1, 24 and 48 hours after dressing removal. The highest non-irritant concentration of the test material and one lower concentration were selected for the topical challenge stage of the main study.
MAIN STUDY
A. INDUCTION EXPOSURE
intradermal injection
Shortly before treatment on Day 0 the hair was removed from an area approximately 40 mm x 60 mm on the shoulder region of each animal with veterinary clippers. A row of three injections (0.1 mL each) was made on each side of the mid-line into a 20 mm x 40 mm area. The injections were:
a) Freund's Complete Adjuvant plus distilled water in the ratio 1:1
b) a 5% w/w formulation of the test material in distilled water
c) a 5% w/w formulation of the test material in a 1:1 preparation of Freund's Complete Adjuvant plus distilled water.
Approximately 24 and 48 hours after intradermal injection the degree of erythema at the test material injection sites (ie. injection site b) was evaluated
- No. of exposures: 1
- Exposure period: 24 / 48
- Test groups: 10 males
- Control group: 5 males
- Site: an area approximately 40 mm x 60 mm on the shoulder region of each animal
- Frequency of applications: once
- Duration: 24 / 48
- Concentrations: 5 % w/w formulation of the test material in distilled water and 5 % w/w formulation of the test material in a 1:1 prepartion of Freud's Complete Adjuant plus distilled water
topical induction
On Day 7 the same area on the shoulder region used previously for intradermal injections was clipped again and treated with a topical application of the test material formulation. A filter paper patch (WHATMAN No. 4: approximate size 40 mm x 20 mm), saturated with the test material formulation (75% w/w in distilled water) was applied to the prepared skin and held in place with a strip of surgical adhesive tape covered with an overlapping length of aluminium foil. The patch and foil were further secured with a strip of elastic adhesive bandage wound in a double layer around the torso of each animal. This occlusive dressing was kept in place for 48 hours.
- No. of exposures: one
- Day(s) of induction: day 7 after induction
- Exposure period: 48 hours
- Site: the same area on the shoulder region used previously for intradermal injections
- Concentrations: 75 % w/w formulation in distilled water
- Evaluation (hr after topical induction): The degree of erythema and oedema was quantified one and twenty-four hours following removal of the patches
B. CHALLENGE EXPOSURE
Shortly before treatment on Day 21, an area of approximately 50 mm x 70 mm on both flanks of each animal, was clipped free of hair with veterinary clippers. A square filter paper patch (WHATMAN No. 4: approximate size 20 mm x 20 mm), saturated with the test material formulation at the maximum non-irritant concentration (75% w/w in distilled water) was applied to the shorn right flank of each animal and was held in place with a strip of surgical adhesive tape. To ensure that the maximum non-irritant concentration was used at challenge, the test material at a concentration of 50% w/w in distilled water was similarly applied to a skin site on the left shorn flank. The patches were occluded with an overlapping length of aluminium foil and secured with a strip of elastic adhesive bandage wound in a double layer around the torso of each animal.
After 24 hours, the dressing was carefully removed and discarded. The challenge sites were swabbed with cotton wool soaked in distilled water to remove residual material. The position of the treatment sites was identified by using a black indelible marker-pen.
Prior to the 24-hour observation the flanks were clipped using veterinary clippers to remove regrown hair.
- No. of exposures: one
- Day(s) of challenge: day 21 after induction
- Exposure period: 24 hours
- Site: an area of approximately 50 mm x 70 mm on both flanks of each animal
- Concentrations: 75 % w/w formulation in distilled water and on the right flank: 50 % w/w formulation in distilled water
- Evaluation (hr after challenge): Approximately 24 and 48 hours after challenge dressing removal, the degree of erythema and oedema was quantified
OTHER: Determination by analysis of the concentration, homogeneity and stability of the test material preparations was not conducted. - Reading:
- other: Reading 24 hours after intradermal induction
- Group:
- test chemical
- Dose level:
- 5 % w/w formulation in distilled water
- Clinical observations:
- Discrete or patchy erythema was noted at the intradermal induction sites of test group animals.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: other: Reading 24 hours after intradermal induction. Group: test group. Dose level: 5 % w/w formulation in distilled water. Clinical observations: Discrete or patchy erythema was noted at the intradermal induction sites of test group animals. .
- Reading:
- other: Reading24 hours after intradermal induction
- Group:
- negative control
- Dose level:
- distilled water
- Clinical observations:
- Discrete or patchy erythema was noted at the intradermal induction sites of control group animals.
- Remarks on result:
- other: Reading: other: Reading24 hours after intradermal induction. Group: negative control. Dose level: distilled water. Clinical observations: Discrete or patchy erythema was noted at the intradermal induction sites of control group animals. .
- Reading:
- other: Reading 1 hour after topical induction
- Group:
- test chemical
- Dose level:
- 75 % w/w and 50 % w/w formulation in distilled water
- Clinical observations:
- Discrete or patchy erythema was noted at the topical induction sites of test group animals.
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: other: Reading 1 hour after topical induction. Group: test group. Dose level: 75 % w/w and 50 % w/w formulation in distilled water. Clinical observations: Discrete or patchy erythema was noted at the topical induction sites of test group animals. .
- Reading:
- other: Reading 1 hours after topical induction
- Group:
- negative control
- Clinical observations:
- No skin reactions were noted at the topical induction sites of control group animals.
- Remarks on result:
- other: Reading: other: Reading 1 hours after topical induction. Group: negative control. Clinical observations: No skin reactions were noted at the topical induction sites of control group animals. .
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 75 % w/w and 50 % w/w formulation in distilled water
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 75 % w/w and 50 % w/w formulation in distilled water. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 75 % w/w and 50 % w/w formulation in distilled water
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 75 % w/w and 50 % w/w formulation in distilled water. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Under the conditions of the test, the test material produced a 0% (0/10) sensitisation rate and was classified as a non-sensitizer to guinea pig skin. Criteria used for interpretation of results: other: EU-GHS
- Conclusions:
- The GLP-study was performed according to the OECD Guideline 406,guinea pig maximisation method according to Magnusson and Kligman without deviations and is considered to be reliable without restrictions (reliability Klimisch 1). The test material did not induce any response. The test material was considered to be not sensitising under the conditions of the test since no evidence of sensitizing or allergenic properties was found.
- Executive summary:
The test item was tested for its sensitising potential according to OECD Guideline 406 in guinea pigs (Driscoll, 2001). The procedure used was performed according to the guinea pig maximisation method - Magnusson and Kligman. The test included three phases: an intradermal induction phase, when test material (0.1mL of a 5 % w/w formulation of the test material in distilled water and 5 % w/w formulation of the test material in a 1:1 preparation of Freud's Complete Adjuvant plus distilled water) is applied intradermally to the test animals; after an one-week rest period, a topical induction with 5 % w/w formulation in water for 24 hours was conducted. Finally after a two-week rest period, a challenge was performed (on day 21 after intradermal induction) with 75 % w/w or 50 % w/w formulation in distilled water for 24 hours. 10 test animals and 5 control animals were used in the study. Treated skin sites were scored according scale as described in the Guinea Pig Maximisation Test of Magnusson B & Kligman. 24- and 48-hour readings were performed after the challenge applications. Under the conditions of the test, the test material produced a 0% (0/10) sensitisation rate. Therefore the substance is not considered to be as skin sensitizer and was classified as a non-sensitizer to guinea pig skin.
Reference
Skin Reactions Observed After Intradermal Induction:
- Discrete or patchy erythema was noted at the intradermal induction sites of test group animals.
- Discrete or patchy erythema was noted at the intradermal induction sites of control group animals.
Table 1 | Intradermal Sighting Test- Summary of Results | |||
VEHICLE: Distilled Water | ||||
Animal Identification | Time of Observation | Concentration of Test Material(%w/w) | Grade of Erythema at Injection Sites | Evidence of Systemic Toxicity |
A | 24 Hours | 1 | 2 | None |
48 Hours | 1 | None | ||
72 Hours | 0 | None | ||
7 Days | 0 | None | ||
B | 24 Hours | 5 | 2 | None |
48 Hours | 1-2 | None | ||
72 Hours | 0 | None | ||
7 Days | 0 | None | ||
The concentration of the test material selected for the intradermal induction stage of the main study was 5% w/w in distilled water |
Table 2 - Intradermal Induction-Individual Skin Reactions | ||||||
Group | Animal Number | Grade of Erythema at Observation Site | ||||
24Hours | 48Hours | |||||
Left Side | Right Side | Left Side | Right Side | |||
TEST | 1 | 1 | 1 | 0 | 0 | |
2 | 1 | 1 | 1 | 0 | ||
3 | 1 | 1 | 0 | 0 | ||
4 | 1 | 1 | 0 | 0 | ||
5 | 1 | 1 | 0 | 0 | ||
6 | 1 | 1 | 1 | 1 | ||
7 | 1 | 1 | 0 | 1 | ||
8 | 1 | 1 | 1 | 1 | ||
9 | 1 | 1 | 0 | 0 | ||
10 | 1 | 1 | 0 | 0 | ||
CONTROL | 11 | 0 | 0 | 0 | 0 | |
12 | 0 | 0 | 0 | 0 | ||
13 | 1 | 1 | 0 | 0 | ||
14 | 1 | 1 | 0 | 0 | ||
15 | 1 | 1 | 0 | 0 |
Skin Reactions Observed After Topical Induction:
- Discrete or patchy erythema was noted at the topical induction sites of test group animals.
- No skin reactions were noted at the topical induction sites of control group animals.
- Bleeding from the intradermal injection sites was noted in six test group animals with residual test material noted at the intradermal injection sites of four test group animals at the 1-hour observation.
Table 3 | Topical Sighting Test for Induction Application (48-Hour Exposure) - Individual Skin Reactions | |||||||||
VEHICLE: | Distilled Water | |||||||||
Animal Identification | Concentration of | Skin Reactions (Hours After Removal of Patches) | ||||||||
Test Material(% w/w) | 1 | 24 | 48 | |||||||
Er | Oe | Other | Er | Oe | Other | Er | Oe | Other | ||
C | 75 | 1 | 0 | - | 0 | 0 | - | 0 | 0 | - |
50 | 1 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
25 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
10 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
D | 75 | 1 | 0 | - | 0 | 0 | - | 0 | 0 | - |
50 | 1 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
25 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
10 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
The concentration of the test material selected for the main study topical induction was 75% w/w in distilled water | ||||||||||
Er = Erythema | ||||||||||
Oe = Oedema | ||||||||||
- = No other reactions noted |
Table 4 | Topical Induction - Individual Skin Reactions | ||||||
Group | Animal Number | Skin Reactions (Hours After Removal of Dressing) | |||||
1 Hour | 24 Hours | ||||||
Er | Oe | Other | Er | Oe | Other | ||
TEST | 1 | 1 | 0 | Bs | 1 | 0 | - |
2 | 1 | 0 | BsRt | 1 | 0 | - | |
3 | 1 | 0 | - | 0 | 0 | - | |
4 | 1 | 0 | Bs | 1 | 0 | - | |
5 | 1 | 0 | BsRt | 0 | 0 | - | |
6 | 1 | 0 | - | 0 | 0 | - | |
7 | 1 | 0 | BsRt | 0 | 0 | - | |
8 | 1 | 0 | BsRt | 1 | 0 | - | |
9 | 1 | 0 | - | 1 | 0 | - | |
10 | 1 | 0 | - | 1 | 0 | - | |
CONTROL | 11 | 0 | 0 | - | 0 | 0 | - |
12 | 0 | 0 | - | 0 | 0 | - | |
13 | 0 | 0 | - | 0 | 0 | - | |
14 | 0 | 0 | - | 0 | 0 | - | |
15 | 0 | 0 | - | 0 | 0 | - | |
Er = Erythema | |||||||
Oe = Oedema | |||||||
Bs = Bleeding from intradermal injection sites | |||||||
- = No other reactions noted | |||||||
Rt = Residual test material |
Skin Reactions Observed After Topical Challenge:
- 75% w/w in Distilled Water: No skin reactions were noted at the challenge sites of the test or control group animals at the 24 or 48-hour observations.
- 50% w/w in Distilled Water: No skin reactions were noted at the challenge sites of the test or control group animals at the 24 or 48-hour observations.
Table 5 | Topical Sighting Test for Challenge Application (24-Hour Exposure) - Individual Skin Reactions | |||||||||
VEHICLE: | Distilled Water | |||||||||
Animal Identification | Concentration of Test Material(% w/w) | Skin Reactions (Hours After Removal of Patches) | ||||||||
1 | 24 | 48 | ||||||||
Er | Oe | Other | Ers | Oe | Other | Er | Oe | Other | ||
E | 75 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
50 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
25 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
10 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
F | 75 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
50 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
25 | 0 | 0 | - | 0 | 0 | 0 | 0 | - | ||
10 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
The concentrations of the test material selected for the main study topical challenge were 75% and 50% w/w in distilled water | ||||||||||
Er = Erythema | ||||||||||
Oe = Oedema | ||||||||||
- = No other reactions noted |
Table 6 | Individual Skin Reactions at Challenge | ||||||||||||
CHALLENGE CONCENTRATIONS: 75%and50%v/v | |||||||||||||
VEHICLE: | Distilled Water | ||||||||||||
Group | Animal Number | Skin Reactions (Hours after Removal of Dressings) | |||||||||||
24Hours | 48Hours | ||||||||||||
50% | 75% | 50% | 75% | ||||||||||
Er | Oe | Other | Er | Oe | Other | Er | Oe | Other | Er | Oe | Other | ||
TEST | 1 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
2 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
3 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
4 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
5 | 0 | 0 | 0 | 0 | 0 | 0 | _ | 0 | 0 | ||||
6 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
7 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
8 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
9 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
10 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
CONTROL | 11 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - |
12 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
13 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
14 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
15 | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | |
Er =Erythema | |||||||||||||
Oe=Oedema | |||||||||||||
- =No other reactions noted |
Table 7 | Summary of Positive Control Data for the Magnusson and Kligman Maximisation Study | ||||||||
Project Number | Date Start | Date End | Number of Animals and Sex* | Positive Control Material | Concentration | Incidence of Sensitisation | |||
Induction | Challenge | ||||||||
Test | Control | Intradermal | Topical | ||||||
039/333 | 22/12/98 | 05/02/99 | 10 Female | 5 Female | 2-Mercaptobenzothiazole | 10% in arachis oil BP | 50%in acetone: PEG400 (70:30) | 50% and 25% in acetone: PEG400 (70:30) | 90% (9/10) |
039/370 | 14/06/99 | 17/07/99 | 10 Male | 5 Male | 2-Mercaptobenzothiazole | 5% in arachis oil BP | 50%in acetone: PEG400 (70:30) | 50% and 25% in acetone: PEG400 (70:30) | 100% (10/10) |
039/422 | 12/01/00 | 05/02/00 | 10 Female | 5 Female | 2-Mercaptobenzothiazole | 5% in arachis oil BP | 50%in acetone: PEG400 (70:30) | 50% and 25% in acetone: PEG400 (70:30) | 100% (10/10) |
039/444 | 29/06/00 | 22/07/00 | 10 Male | 5 Male | 2-Mercaptobenzothiazole | 5% in arachis oil BP | 50%in acetone: PEG400 (70:30) | 50% and 25% in acetone: PEG400 (70:30) | 100% (9/9) |
039/446 | 28/06/00 | 06/08/00 | 10 Male | 5 Male | cc-Hexylcinnamaldehyde | 5% in arachis oil BP | 100% | 100% and 75% in arachis oil BP | 50% (5/10) |
039/458 | 25/01/01 | 25/02/01 | 10 Male | 5 Male | oc-Hexylcinnamaldehyde | 5% in arachis oil BP | 100% | 100% and 75% in arachis oil BP | 40% (4/10) |
*All animals supplied bv David Hall Ltd. Burton-on-Trent. Staffordshire. UK |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
In vivo skin sensitisation
The test item was tested for its sensitising potential according to OECD Guideline 406 in guinea pigs (Driscoll, 2001). The procedure used was performed according to the guinea pig maximisation method - Magnusson and Kligman. The test included three phases: an intradermal induction phase, when test material (0.1mL of a 5 % w/w formulation of the test material in distilled water and 5 % w/w formulation of the test material in a 1:1 preparation of Freud's Complete Adjuvant plus distilled water) is applied intradermally to the test animals; after an one-week rest period, a topical induction with 5 % w/w formulation in water for 24 hours was conducted. Finally after a two-week rest period, a challenge was performed (on day 21 after intradermal induction) with 75 % w/w or 50 % w/w formulation in distilled water for 24 hours. 10 test animals and 5 control animals were used in the study. Treated skin sites were scored according scale as described in the Guinea Pig Maximisation Test of Magnusson B & Kligman. 24- and 48-hour readings were performed after the challenge applications. Under the conditions of the test, the test material produced a 0% (0/10) sensitisation rate. Therefore the substance is not considered to be a skin sensitizer and was classified as a non-sensitizer to guinea pig skin.
Prediction using TOXTREE
According to the results of TOXTREE modelling tool, 3-(1-Pyridinio)-1-propanesulfonate is estimated to be negative for skin sensitization potential. The test substance is not electrophile reactive. No structural alerts are identified for the possibility of nucleophilic substitution, Shiff base formation or addition-elimination reactions. There are no functional groups which can act as Michael acceptors.
Migrated from Short description of key information:
1) Safepharm, 2001, skin sensitisation according to the guinea pig maximisation method of Magnusson and Kligman, Dunking-heartley, solvent distilled water
2) Prediction using TOXTREE (v.2.5.0), Chemservice S.A., 2011)
Justification for selection of skin sensitisation endpoint:
GLP-Guideline study
Justification for classification or non-classification
Skin sensitisation:
According to the European regulation (EC) No. 1272/2008, the test material does not meet the criteria for classification and will not require any symbol or risk phrase.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.